mRNA COVID-19 vaccines may improve cancer survival when combined with immunotherapy

gavi.org

A study suggests mRNA COVID-19 vaccines may double cancer survival rates when combined with immunotherapy. Researchers found that patients receiving mRNA COVID-19 vaccines alongside immunotherapy had significantly higher survival rates, attributing this to the vaccines' ability to boost the immune system's response against tumors. This discovery could lead to a low-cost, widely accessible treatment option, with a nationwide clinical trial planned for lung cancer patients.


With a significance score of 5.9, this news ranks in the top 0.3% of today's 27806 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: